The National Health Service in England started restricting gender treatments for children this month, making it the fifth European country to limit the medications because of a lack of evidence of their benefits and concern about long-term harms. England’s change resulted from a four-year review released Tuesday evening by Dr. Hilary Cass, an independent pediatrician. […]
Read More